Retrospective Study
Copyright ©The Author(s) 2024.
World J Orthop. Apr 18, 2024; 15(4): 337-345
Published online Apr 18, 2024. doi: 10.5312/wjo.v15.i4.337
Table 1 Patient characteristics of included patients, n (%)/mean ± SD

Fair hip function after surgery (n = 67)
Excellent hip function after surgery (n = 52)
Total (n = 119)
t/χ2
P value
Age (yr)76.88 ± 12.5475.79 ± 12.0576.4 ± 12.290.5380.660
Sex 0.0050.946
Female46 (68.7)36 (69.2)82 (68.9)
Male21 (31.3)16 (30.8)37 (31.1)
Hypertension0.1490.699
Yes41 (61.2)30 (57.7)71 (59.7)
No26 (38.8)22 (42.3)48 (40.3)
Diabetes0.0080.929
Yes15 (22.4)12 (23.1)27 (22.7)
No52 (77.6)40 (76.9)92 (77.3)
Types0.0300.862
Femoral neck32 (47.8)24 (46.2)56 (47.1)
Trochanteric35 (52.2)28 (53.8)63 (52.9)
Surgical method0.0160.899
PFNA34 (50.7)27 (51.9)61 (51.3)
THA33 (49.3)25 (48.1)58 (48.7)
Time from injury to
Surgery 4.69 ± 2.855.15 ± 2.824.89 ± 2.840.8760.425
Neut6.09 ± 2.386.49 ± 2.366.29 ± 2.360.6430.806
Lymph1.20 ± 0.611.14 ± 0.441.17 ± 0.530.4550.152
IL-653.08 ± 28.2424.58 ± 9.5737.03 ± 24.432.540.012
IL-847.99 ± 23.3924.06 ± 10.4834.52 ± 20.987.47< 0.01
IL-1011.43 ± 4.839.44 ± 3.8910.31 ± 4.422.490.014
CRP21.76 ± 18.1210.00 ± 5.5515.14 ± 13.915.022< 0.01
C1q207.44 ± 49.24174.84 ± 66.86189.08 ± 61.752.9490.004
Table 2 Outcomes
Fair hip function after surgery (n = 67)
Excellent hip function after surgery (n = 52)
F. group vs E. group

Outcome
mean ± SD
mean ± SD
Mean diff. (95%CI)
P value
VAS2.03 ± 0.821.85 ± 0.780.18 (-0.11-0.48)0.827
Length of hospitalization14.31 ± 7.8513.72 ± 3.980.59 (1.60-2.78)0.036
Table 3 Logistic regression analysis on the risk factors of postoperative fair joint function in patients with hip fracture
Items
β
SE
OR
95%CI
P
IL-6 > 20 pg/mL1.1220.4613.0701.243-7.5790.015
IL-8 > 21.4 pg/mL1.3420.4783.8271.498-9.7730.005
IL-10 > 5.90 pg/mL0.7190.4382.0530.871-4.8410.10
CRP > 10 mg/L0.7620.3792.1421.020-4.4980.044
C1q > 233 mg/L0.8500.3882.3391.094-5.0040.028